PMID- 10542228 OWN - NLM STAT- MEDLINE DCOM- 19991213 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 274 IP - 45 DP - 1999 Nov 5 TI - The role of DOC-2/DAB2 protein phosphorylation in the inhibition of AP-1 activity. An underlying mechanism of its tumor-suppressive function in prostate cancer. PG - 31981-6 AB - DOC-2/DAB2, a novel phosphoprotein with signal-transducing capability, inhibits human prostatic cancer cells (Tseng, C.-P., Ely, B. D., Li, Y., Pong, R.-C., and Hsieh, J.-T. (1998) Endocrinology 139, 3542-3553). However, its mechanism of action is not understood completely. This study delineates the functional significance of DOC-2/DAB2 protein phosphorylation and demonstrates that in vivo activation of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) induces DOC-2/DAB2 phosphorylation, including a serine residue at position 24. Mutation of Ser(24) to Ala reduced DOC-2/DAB2 phosphorylation by PKC. Using a synthetic Ser(24) peptide (APS(24)KKEKKKGSEKTD) or recombinant DOC-2/DAB2 as substrates, PKCbetaII, PKCgamma, and PKCdelta (but not casein kinase II) directly phosphorylated Ser(24) in vitro. This indicates that DOC-2/DAB2 is a PKC-specific substrate. Since expression of wild-type DOC-2/DAB2, but not the S24A mutant, inhibited TPA-induced AP-1 activity in prostatic epithelial cells, phosphorylation of Ser(24) appears to play a critical role in modulating TPA-induced AP-1 activity. Taken together, these data suggest that PKC-regulated phosphorylation of DOC-2/DAB2 protein may help its growth inhibitory function. FAU - Tseng, C P AU - Tseng CP AD - Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9110, USA. FAU - Ely, B D AU - Ely BD FAU - Pong, R C AU - Pong RC FAU - Wang, Z AU - Wang Z FAU - Zhou, J AU - Zhou J FAU - Hsieh, J T AU - Hsieh JT LA - eng GR - CA59939/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Adaptor Proteins, Vesicular Transport) RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (DAB2 protein, human) RN - 0 (Proteins) RN - 0 (Transcription Factor AP-1) RN - 0 (Tumor Suppressor Proteins) RN - 452VLY9402 (Serine) RN - EC 2.7.11.13 (Protein Kinase C) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Adaptor Proteins, Signal Transducing MH - *Adaptor Proteins, Vesicular Transport MH - Amino Acid Sequence MH - Animals MH - Apoptosis Regulatory Proteins MH - COS Cells MH - *Genes, Tumor Suppressor MH - Humans MH - Male MH - Molecular Sequence Data MH - Phosphorylation MH - Prostatic Neoplasms/*metabolism MH - Protein Kinase C/metabolism MH - Proteins/*metabolism MH - Serine/metabolism MH - Tetradecanoylphorbol Acetate/pharmacology MH - Transcription Factor AP-1/*antagonists & inhibitors MH - Tumor Suppressor Proteins EDAT- 1999/11/05 00:00 MHDA- 1999/11/05 00:01 CRDT- 1999/11/05 00:00 PHST- 1999/11/05 00:00 [pubmed] PHST- 1999/11/05 00:01 [medline] PHST- 1999/11/05 00:00 [entrez] AID - 10.1074/jbc.274.45.31981 [doi] AID - S0021-9258(19)51516-2 [pii] PST - ppublish SO - J Biol Chem. 1999 Nov 5;274(45):31981-6. doi: 10.1074/jbc.274.45.31981.